memo - Magazine of European Medical Oncology

New approaches for the classification of early breast cancer, a heterogeneous disease entity

• Leading article

Z. Kahán

Long-term results of national treatment trials in childhood acute lymphoblastic leukaemia in several Middle/East European countries

• Editorial

J. Starý

Skeletal Care Academy 2011 – CECOG Translational

• CECOG News

The concept of comprehensive cancer centres of medical universities: A summary of thoughts

• Commentary

C. C. Zielinski

The current TNM classification of breast carcinomas: Controversial issues in early breast cancer

• Short review

G. Cserni

The use of mammographic tumour feature significantly improves outcome prediction of breast cancers smaller than 15 mm: a reproducibility study from two comprehensive breast centres

• Original report

L. Tabár, L. Tucker, R. R. Davenport, J. G. Mullet, A. T. Hsiu-Hsi Chen, A. Ming-Fang Yen, S. Yueh-Hsia Chiu, J. Gladwell, K. Olinger, P. B. Dean

Molecular genetic tests in the prediction of the prognosis of breast cancer

• Short review

F. R. Stoddard II, A. M. Szasz, B. Szekely, A.-M. Tokes, J. Kulka

Conventional and non-conventional pathologic workup of specimens with early breast carcinomas

• Short review

T. Tot

Laparoscopic liver resection – a substantial progress towards multimodal treatment of metastases

• Short review

K. Emmanuel, C. Augschöll, D. Öfner

Treatment of invasive fungal infections

• Short review

R. Bellmann, S. Weiler

History of treatment and long-term outcome in children with acute lymphoblastic leukaemia in Serbia

• Short review

D. Micic, B. Slavkovic, N. Rasovic Gvozdenovic, M. Kuzmanovic, L. Dokmanovic, N. Krstovski, D. Skoric, N. Konstantinidis, G. Kostic, J. Predojevic, D. Janic

History of treatment and long-term outcome of childhood acute lymphoblastic leukemia in Slovenia

• Short review

S. Avcin, T. Prelog, M. Kavcic, L. Kitanovski, J. Anzic, M. Benedik Dolnicar, V. Rajic, L. Zadravec Zaletel, M. Debeljak, J. Jazbec

Long-term results in children with standard risk acute lymphoblastic leukaemia treated with 5.0 g/m2 versus 3.0 g/m2 methotrexate i.v. according to the modified ALL-BFM 90 protocol. The report of Polish paediatric Leukemia/lymphoma study group

• Short review

K. Derwich, J. Wachowiak, O. Zając-Spychała, A. Balcerska, W. Balwierz, A. Chybicka, J. R. Kowalczyk, M. Matysiak, T. Jackowska, D. Sońta-Jakimczyk, T. Szczepański, M. Wysocki

Results of acute lymphoblastic leukemia treatment in children in the Slovak Republic

• Short review

E. Kaiserová, E. Bubánska, I. Oravkinová, Z. Šubová, A. Kolenová, A. Foltinová, J. Čáp

History of treatment and long-term outcome in children with acute lymphoblastic leukemia in the Czech Republic

• Short review

J. Starý, V. Mihál, P. Smíšek, B. Blažek, Y. Jabali, H. Hrstková, J. Hak, D. Procházková, Z. Černá, J. Štěrba, J. Trka, O. Hrušák, J. Zuna, E. Mejstříková, I. Janotová, P. Sedláček, H. Ptoszková, D. Pospíšilová, K. Toušovská, P. Timr, V. Vávra, K. Zdráhalová, L. Šrámková, Z. Zemanová, M. Jarošová, P. Gajdoš, O. Hrodek